Hubei Hongyuan Pharmaceutical Technology Co., Ltd. Share Price
Equities
301246
CNE100005ZB9
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.62 CNY | -1.66% | -0.60% | -36.03% |
Sales 2022 | 206.37Cr 29Cr 2.38TCr | Sales 2023 | 205.49Cr 28Cr 2.37TCr | Capitalization | 1.04TCr 143.69Cr 12TCr |
---|---|---|---|---|---|
Net income 2022 | 44Cr 6.01Cr 502.01Cr | Net income 2023 | 8.7Cr 1.2Cr 100.4Cr | EV / Sales 2022 * | - |
Net cash position 2022 | 5.1Cr 70.58L 59Cr | Net cash position 2023 | 183.05Cr 25Cr 2.11TCr | EV / Sales 2023 | 4.17 x |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
116
x | Employees | 2,075 |
Yield 2022 * |
-
| Yield 2023 |
0.19% | Free-Float | 37.32% |
1 day | -1.66% | ||
1 week | -0.60% | ||
Current month | +1.96% | ||
1 month | +0.18% | ||
3 months | -18.81% | ||
6 months | -40.64% | ||
Current year | -36.03% |
Managers | Title | Age | Since |
---|---|---|---|
Shuang Xi Xu
CEO | Chief Executive Officer | 58 | - |
Gao Liang Lei
CHM | Chairman | 59 | - |
Ke Feng Zeng
DFI | Director of Finance/CFO | 39 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Qing Xie
BRD | Director/Board Member | 61 | - |
Si Yuan Cheng
BRD | Director/Board Member | 51 | - |
Zhi Hua Deng
BRD | Director/Board Member | 54 | - |
Date | Price | Change | Volume |
---|---|---|---|
14/24/14 | 16.62 | -1.66% | 10,279,080 |
13/24/13 | 16.9 | -5.80% | 15,294,090 |
10/24/10 | 17.94 | +2.05% | 25,233,370 |
09/24/09 | 17.58 | +2.75% | 17,360,230 |
08/24/08 | 17.11 | +2.33% | 12,261,910 |
End-of-day quote Shenzhen S.E., May 14, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-36.03% | 93Cr | |
+31.06% | 68TCr | |
+30.35% | 59TCr | |
-3.42% | 36TCr | |
+18.02% | 33TCr | |
+4.27% | 28TCr | |
+15.53% | 24TCr | |
+10.16% | 21TCr | |
-8.14% | 20TCr | |
+8.12% | 17TCr |
- Stock Market
- Equities
- 301246 Stock